Skip Navigation


Annals of Oncology Advance Access originally published online on July 19, 2005
Annals of Oncology 2005 16(12):1979-1980; doi:10.1093/annonc/mdi387
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/12/1979-a    most recent
mdi387v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Del Mastro, L.
Right arrow Articles by Perrone, F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Del Mastro, L.
Right arrow Articles by Perrone, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Letter to the Editor

Reply to "Weekly paclitaxel in elderly breast cancer patients", by C. Smorenburg et al. (Ann Oncol 2005; 16: 1979)

The first 10% of the full text of this article appears below.

Smorenburg and ten Tije rightly suggest that the higher than previously reported rate of cardiotoxicity observed in the GIOGer study on weekly paclitaxel in elderly patients . . . [Full Text of this Article]

L. Del Mastro1,* and F. Perrone2

1 Department of Medical Oncology, National Cancer Research Institute, Genoa; 2 Clinical Trials Unit, NCI, Naples, Italy

* E-mail: lucia.delmastro@istge.it


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?